 study vancomycin versus teicoplanin treatment gram-positive bacterial infections immunocompromised hosts immunocompromised patients severe infection due gram-positive organisms vancomycin teicoplanin Extensive cancer present patients month types infections bacteremias central catheters skin soft tissue infections bacteremia others bronchopneumonia frequent pathogen Staphylococcus epidermidis Staphylococcus aureus Microbiological eradication evaluable patients vancomycin patients teicoplanin Clinical cure improvement patients patients significant side effects teicoplanin contrast reversible increases serum creatinine patients skin rashes patients vancomycin Superinfection patients vancomycin patients teicoplanin relation peak concentration serum steady state bactericidal titers outcome